Istraživači
Radosavljević, Davorin
Godina
Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
---|---|---|---|---|
2023 | Review of the Clinical Pharmacokinetics, Efficacy and Safety of Pembrolizumab (✓) | Homšek Ana ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Naučni članak | 22M22 - Rad u istaknutom međ. časopisu |
2022 | Perioperative bevacizumab in the treatment of colorectal cancer in patients with liver metastases (✓) | Nikolić, Ivan ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Naučni članak | 51M51 - Rad u vrhunskom časopisu nac. značaja |
2022 | Evaluation of Clinical and Genetic Determinants of Treatment OutCome In EGFR Mutation Positive Advanced Lung Adenocarcinoma (✓) | Jokic, Vera M; Savic-Vujovic, Katarina R ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Naučni članak | 22M22 - Rad u istaknutom međ. časopisu |
2022 | Low-Cost Genetic and Clinical Predictors of Response and Toxicity of Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer (✓) | Spasić, Jelena ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Naučni članak | 22M22 - Rad u istaknutom međ. časopisu |
2022 | Lung Cancer in Serbia (✓) | Čavić Milena ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Naučni članak | 21aM21a - Rad u međ. časopisu izuzetnih vrednosti |
2021 | Prognostic Factors for Post-Recurrence Survival in Stage II and III Colorectal Carcinoma Patients (✓) | Nikolic Neda ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Naučni članak | 22M22 - Rad u istaknutom međ. časopisu |
2021 | The value of Th2-related thymic stromal lymphopoietin as a prognostic and predictive biomarker in non-small cell lung cancer (✓) | Cavic, Milena R ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
2021 | Exploring the real-world effect of the SARS-CoV-2 pandemic on the molecular diagnostics for cancer patients and high-risk individuals (✓) | Čavić, Milena ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Naučni članak | 21M21 - Rad u vrhunskom međ. časopisu |
2021 | Hematological parameters in EGFR-mutated advanced NSCLC patients treated with TKIs: predicting survival and toxicity (✓) | Jokić, Vera; Savić-Vujović, Katarina ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Naučni članak | 22M22 - Rad u istaknutom međ. časopisu |
2021 | The Value of Clinical and Genetic Factors in Pain Management in EGFR Mutated Advanced Lung Adenocarcinoma Patients (✓) | Cavic, Milena R ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
2020 | A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries (✓) | Belkacemi, Yazid; Grellier, Noemie; Ghith, Sahar; Debbi, Kamel; Coraggio, Gabriele; Bounedjar, Adda; Samlali, Redouane; Tsoutsou, Pauletta G.; Ozsahin, Mahmut; Chauvet, Marie-Pierre;
Turkan, Sedat; Boussen, Hamouda; Kuten, Abraham; Tešanović, Dušanka; Errihani, Hassan; Benna, Farouk; Bouzid, Kamel; Idbaih, Ahmed; Mokhtari, Karima; Popović, Lazar; Spano, Jean-Philippe; Lotz, Jean-Pierre; Cherif, Aziz; To, Hahn; Kovčin, Vladimir
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Naučni članak | 21M21 - Rad u vrhunskom međ. časopisu |
2019 | Tracking resistance to tyrosine kinase inhibitors (TKIs) by EGFR mutation testing from liquid biopsy of advanced lung adenocarcinoma patients (✓) | Jokić V; Spasić Jelena ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
2019 | The predictive value of haematological parameters on the progression-free survival in advanced lung adenocarcinoma patients treated with tyrosine kinase inhibitors in Serbia (✓) | Vera Jokic; Jelena Spasic ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
2019 | Tyrosine kinase inhibitor-induced toxicity in advanced lung adenocarcinoma patients treated at the Institute for Oncology and Radiology of Serbia (✓) | Vera Jokic; Čavić, Milena R. ![]() ![]() ![]() ![]() ![]() ![]() | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
2019 | EGFR mutation testing of advanced lung adenocarcinoma patients in Serbia – advantages and setbacks of liquid biopsy testing in developing countries (✓) | Spasić, Jelena ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
2018 | P3.01-85 Real-World Gefitinib 1st line treatment of patients with advanced NSCLC and EGFR mutations - Serbian single center experience (✓) | Radosavljević, Davorin Z. ![]() ![]() ![]() ![]() ![]() ![]() | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
2018 | TP53 and DNA-repair gene polymorphisms genotyping as a low-cost lung adenocarcinoma screening tool. (✓) | Čavić, Milena ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Naučni članak | 21M21 - Rad u vrhunskom međ. časopisu |
2018 | Peripheral White Blood cell subsets in Metastatic colorectal cancer Patients Treated with cetuximab: The Potential Clinical Relevance (✓) | Matić, Ivana ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Naučni članak | 21M21 - Rad u vrhunskom međ. časopisu |
2018 | Mapping cancer research across Central and Eastern Europe, the Russian Federation and Central Asia: Implications for future national cancer control planning (✓) | Begum, Mursheda; Lewison, Grant; Jassem, Jacek; Mixich, Vlad; Cufer, Tanja; Nurgozhin, Talgat; Shabalkin, Pavel; Kutluk, Tezer; Voko, Zoltan; Radosavljević, Davorin ![]() ![]()
Vrdoljiak, Eduard; Eniu, Alexandru; Walewski, Jan; Aggarwal, Ajay; Lawler, Mark; Sullivan, Richard;
| Naučni članak | 21M21 - Rad u vrhunskom međ. časopisu |
2017 | Durable complete remission of poor performance status metastatic lung adenocarcinoma patient treated with second-line erlotinib: a case report (✓) | Jovanović, Dragana M. ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Naučni članak | 22M22 - Rad u istaknutom međ. časopisu |